West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics


West Pharmaceutical Services, Inc. (WST): $455.22

6.04 (+1.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

WST POWR Grades


  • WST scores best on the Sentiment dimension, with a Sentiment rank ahead of 96.96% of US stocks.
  • The strongest trend for WST is in Quality, which has been heading down over the past 48 weeks.
  • WST ranks lowest in Momentum; there it ranks in the 15th percentile.

WST Stock Summary

  • WST has a higher market value than 91.99% of US stocks; more precisely, its current market capitalization is $33,229,926,299.
  • WST's went public 33.74 years ago, making it older than 89.18% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for WST is currently 66.41, higher than 93.36% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to WST, based on their financial statements, market capitalization, and price volatility, are CSGP, CE, LOGI, ALGN, and PTON.
  • WST's SEC filings can be seen here. And to visit West Pharmaceutical Services Inc's official web site, go to www.westpharma.com.

WST Valuation Summary

  • In comparison to the median Healthcare stock, WST's price/sales ratio is 16.3% higher, now standing at 13.2.
  • WST's price/earnings ratio has moved NA NA over the prior 243 months.
  • Over the past 243 months, WST's price/earnings ratio has gone NA NA.

Below are key valuation metrics over time for WST.

Stock Date P/S P/B P/E EV/EBIT
WST 2021-08-31 13.2 16.4 64.3 52.6
WST 2021-08-30 13.2 16.4 64.4 52.7
WST 2021-08-27 13.1 16.3 63.7 52.1
WST 2021-08-26 13.1 16.3 63.6 52.1
WST 2021-08-25 13.0 16.2 63.3 51.8
WST 2021-08-24 13.1 16.2 63.5 52.0

WST Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at 30.98%.
  • The 2 year net income to common stockholders growth rate now stands at 95.35%.
  • The 5 year price growth rate now stands at 221.4%.
WST's revenue has moved up $987,800,000 over the prior 52 months.

The table below shows WST's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 2,522.5 500.4 519.2
2021-03-31 2,326.1 504.1 423.1
2020-12-31 2,146.9 472.5 346.2
2020-09-30 2,037.3 430.2 311.7
2020-06-30 1,945.4 419.7 285.7
2020-03-31 1,887.9 376.7 260.6

WST's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • WST has a Quality Grade of C, ranking ahead of 73.5% of graded US stocks.
  • WST's asset turnover comes in at 0.913 -- ranking 8th of 22 Rubber and Plastic Products stocks.
  • TUP, MYE, and ENTG are the stocks whose asset turnover ratios are most correlated with WST.

The table below shows WST's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.913 0.394 0.328
2021-03-31 0.885 0.375 0.281
2020-12-31 0.857 0.358 0.238
2020-09-30 0.852 0.348 0.220
2020-06-30 0.850 0.341 0.206
2020-03-31 0.850 0.332 0.195

WST Price Target

For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $436.00 Average Broker Recommendation 1.5 (Moderate Buy)

WST Stock Price Chart Interactive Chart >

Price chart for WST

WST Price/Volume Stats

Current price $455.22 52-week high $475.35
Prev. close $449.18 52-week low $253.85
Day low $448.41 Volume 206,300
Day high $459.62 Avg. volume 400,329
50-day MA $429.17 Dividend yield 0.15%
200-day MA $338.61 Market Cap 33.68B

West Pharmaceutical Services, Inc. (WST) Company Bio


West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.


WST Latest News Stream


Event/Time News Detail
Loading, please wait...

WST Latest Social Stream


Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.

Bet on These 3 MedTech Growth Stocks for 2021 & Beyond

Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.

Yahoo | September 22, 2021

The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems

The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems

Yahoo | September 17, 2021

3 Dental Stocks Poised to Perform Well in Second-Half 2021

Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.

Yahoo | September 16, 2021

Top Ranked Momentum Stocks to Buy for September 15th

CACC, UFPT, WST, and CASH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 15, 2021.

Yahoo | September 15, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bicycle Therapeutics plc (NASDAQ: BCYC ) C4 Therapeutics, Inc. (NASDAQ: CCCC ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) DexCom, Inc. (NASDAQ: DXCM ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Medtronic plc (NYSE: MDT ) MiMedx Group, Inc. (NASDAQ: MDXG ) PDS Biotechnology Corporation (NASDAQ: PDSB ) Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) Quest Diagnostics Incorporated (NYSE: DGX ) (raised its full-year guidance) ResMed Inc. (NYSE: RMD ) Stryker Corporation (NYSE: SYK ) Tango Therapeutics, Inc. (N...

Benzinga | September 10, 2021

Read More 'WST' Stories Here

WST Price Returns

1-mo 2.41%
3-mo 26.49%
6-mo 62.56%
1-year 73.04%
3-year 275.47%
5-year 542.26%
YTD 60.93%
2020 89.05%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9602 seconds.